Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Embecta Corporation (EMBC)
NASDAQ:EMBC
Holding EMBC?
Track your performance easily
EMBC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.93 - $21.48
Previous Close$20.23
Volume1.41M
Average Volume (3M)384.08K
Market Cap
$1.16B
Enterprise Value$2.50B
Total Cash (Recent Filing)$267.50M
Total Debt (Recent Filing)$1.61B
Price to Earnings (P/E)14.9
Beta0.94
Next Earnings
Feb 18, 2025EPS Estimate
$0.44Last Dividend Ex-Date
Dec 06, 2024Dividend Yield3%
Share Statistics
EPS (TTM)1.35
Shares Outstanding58,130,561
10 Day Avg. Volume453,454
30 Day Avg. Volume384,077
Standard Deviation0.16
R-Squared0.14
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-1.59
Price to Sales (P/S)1.03
Price to Cash Flow (P/CF)10.90
P/FCF Ratio5.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.23
Enterprise Value/Gross Profit3.40
Enterprise Value/Ebitda28.27
Forecast
1Y Price Target
$22.00Price Target Upside8.75% Upside
Rating ConsensusHold
Number of Analyst Covering3
Embecta Corporation News
Bulls Say, Bears Say
Bulls Say
Cost ManagementThe organizational restructuring plan, along with the discontinuation of the patch pump program, is expected to generate annualized pre-tax cost savings of $60-$65M.
Financial PerformanceThe valuation of Embecta is considered at the bottom of the peer group, making the stock an attractive buy.
Strategic DecisionsDiscontinuing the patch pump program removes substantial forward costs, providing financial relief.
Bears Say
Financial OutlookRevenue guidance for 2025 is set below current market expectations, indicating a potential decline in financial performance.
Financial PerformanceAdjusted EBITDA missed consensus estimates, indicating a performance shortfall.
Revenue GrowthThe business seems fairly valued for its cash flow value, indicating limited revenue growth acceleration.
---
Ownership Overview
2.06% Insiders
29.57% Mutual Funds
23.83% Other Institutional Investors
16.33% Public Companies and
Individual Investors
EMBC FAQ
What was Embecta Corporation’s price range in the past 12 months?
Embecta Corporation lowest stock price was $9.93 and its highest was $21.48 in the past 12 months.
What is Embecta Corporation’s market cap?
Currently, no data Available
When is Embecta Corporation’s upcoming earnings report date?
Embecta Corporation’s upcoming earnings report date is Feb 18, 2025 which is in 58 days.
How were Embecta Corporation’s earnings last quarter?
Embecta Corporation released its earnings results on Nov 26, 2024. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.362 by $0.088.
Is Embecta Corporation overvalued?
According to Wall Street analysts Embecta Corporation’s price is currently Undervalued.
Does Embecta Corporation pay dividends?
Embecta Corporation pays a Quarterly dividend of $0.15 which represents an annual dividend yield of 3%. See more information on Embecta Corporation dividends here
What is Embecta Corporation’s EPS estimate?
Embecta Corporation’s EPS estimate is $0.44.
How many shares outstanding does Embecta Corporation have?
Embecta Corporation has 58,130,560 shares outstanding.
What happened to Embecta Corporation’s price movement after its last earnings report?
Embecta Corporation reported an EPS of $0.45 in its last earnings report, beating expectations of $0.362. Following the earnings report the stock price went up 29.79%.
Which hedge fund is a major shareholder of Embecta Corporation?
Among the largest hedge funds holding Embecta Corporation’s share is Deerfield Management Company, LP. It holds Embecta Corporation’s shares valued at 38M.
---
Embecta Corporation Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$22.00 (8.75% Upside)
$22.00 (8.75% Upside)
Blogger Sentiment
Bullish
EMBC Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 385.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.2%
Last 30 Days ▲ 6.4%
Last 30 Days ▲ 6.4%
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.17%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
5.84%
Trailing 12-Months
Company Description
Embecta Corporation
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
---
EMBC Company Deck
---
EMBC Earnings Call
Q4 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
Embecta demonstrated strong execution and financial resilience in a challenging macro environment, including successful debt reduction and product launches. However, significant challenges remain with the discontinuation of the insulin patch pump program and expected pricing headwinds in 2025.Read More>---
EMBC Stock 12 Month Forecast
Average Price Target
$22.00
▲(8.75% Upside)
Technical Analysis
Best Analysts Covering EMBC
1 Year
1 Year Success Rate
5/7 ratings generated profit
1 Year Average Return
+2.19%
assigned a sell rating 25 days ago
Copying Travis Steed's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +2.19% per trade.
---